Mirum Pharmaceuticals, Inc.
MIRM· Nasdaq
Released Nov 11, 2020, after the close
10-Q filed Nov 12, 2020, 43 days after period end · 0001564590-20-053201
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$21.51M | -$15.09M | -$67.00K |
| EPS Diluted | -$0.86 | -$0.84 | -$0.14 |
Mirum Pharmaceuticals, Inc. · CIK 1759425 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.